These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 16873698

  • 1. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [Abstract] [Full Text] [Related]

  • 2. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM.
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [Abstract] [Full Text] [Related]

  • 3. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [Abstract] [Full Text] [Related]

  • 4. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL, Thomas W, Schmitz KH.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [Abstract] [Full Text] [Related]

  • 5. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL, Elofsson S, Brismar K.
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [Abstract] [Full Text] [Related]

  • 6. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects.
    López-Bermejo A, Hernández-Aguado I, Vera IJ, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernández-Real JM.
    Thromb Haemost; 2007 Feb; 97(2):240-4. PubMed ID: 17264953
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 10. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 11. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 12. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 13. Gender differences in the insulin-like growth factor axis response to a glucose load.
    Flanagan DE, Holt RI, Owens PC, Cockington RJ, Moore VM, Robinson JS, Godsland IF, Phillips DI.
    Acta Physiol (Oxf); 2006 Jul; 187(3):371-8. PubMed ID: 16776662
    [Abstract] [Full Text] [Related]

  • 14. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO.
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [Abstract] [Full Text] [Related]

  • 15. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 16. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ, Lukanova A, Rinaldi S, Lundin E, Norat T, Palmqvist R, Stattin P, Riboli E, Hallmans G, Kaaks R.
    Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
    [Abstract] [Full Text] [Related]

  • 17. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 18. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 19. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
    Ricart W, Fernández-Real JM.
    Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
    [Abstract] [Full Text] [Related]

  • 20. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.